Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CDC42 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MPDZ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SLC6A8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD8A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
L1CAM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLITRK5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC401463 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
NKAIN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BEST3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GRB7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HRASLS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDON - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MMP24-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC12A7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LMLN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BTG4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on